Schumitzky A - Search Results

1

Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.

Louie A, Liu W, VanGuilder M, Neely MN, Schumitzky A, Jelliffe R, Fikes S, Kurhanewicz S, Robbins N, Brown D, Baluya D, Drusano GL. Louie A, et al. Among authors: schumitzky a. J Infect Dis. 2015 Apr 15;211(8):1326-33. doi: 10.1093/infdis/jiu603. Epub 2014 Oct 31. J Infect Dis. 2015. PMID: 25362196 Free PMC article.

2

Modeling, adaptive control, and optimal drug therapy.

Jelliffe RW, Schumitzky A. Jelliffe RW, et al. Among authors: schumitzky a. Med Prog Technol. 1990 May;16(1-2):95-110. Med Prog Technol. 1990. PMID: 2138702 Review.

3

Pharmaco-informatics: more precise drug therapy from "multiple model" (MM) stochastic adaptive control regimens: evaluation with simulated vancomycin therapy.

Jelliffe RW, Bayard D, Schumitzky A, Milman M, Van Guilder M. Jelliffe RW, et al. Among authors: schumitzky a. Proc Annu Symp Comput Appl Med Care. 1994:972. Proc Annu Symp Comput Appl Med Care. 1994. PMID: 7950076 Free PMC article.

4

Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.

Jelliffe RW, Schumitzky A, Van Guilder M, Liu M, Hu L, Maire P, Gomis P, Barbaut X, Tahani B. Jelliffe RW, et al. Among authors: schumitzky a. Ther Drug Monit. 1993 Oct;15(5):380-93. Ther Drug Monit. 1993. PMID: 8249044 Review.

5

Pharmaco-informatics: more precise drug therapy from 'multiple model' (MM) adaptive control regimens: evaluation with simulated vancomycin therapy.

Jelliffe RW, Bayard D, Schumitzky A, Milman M, Van Guilder M. Jelliffe RW, et al. Among authors: schumitzky a. Medinfo. 1995;8 Pt 2:1106-10. Medinfo. 1995. PMID: 8591381

6

Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.

Jelliffe RW, Schumitzky A, Bayard D, Milman M, Van Guilder M, Wang X, Jiang F, Barbaut X, Maire P. Jelliffe RW, et al. Among authors: schumitzky a. Clin Pharmacokinet. 1998 Jan;34(1):57-77. doi: 10.2165/00003088-199834010-00003. Clin Pharmacokinet. 1998. PMID: 9474473 Review.

7

Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens.

Jelliffe R, Bayard D, Milman M, Van Guilder M, Schumitzky A. Jelliffe R, et al. Among authors: schumitzky a. Ther Drug Monit. 2000 Jun;22(3):346-53. doi: 10.1097/00007691-200006000-00018. Ther Drug Monit. 2000. PMID: 10850404

8

Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.

Jelliffe R, Schumitzky A, Van Guilder M. Jelliffe R, et al. Among authors: schumitzky a. Ther Drug Monit. 2000 Jun;22(3):354-65. doi: 10.1097/00007691-200006000-00019. Ther Drug Monit. 2000. PMID: 10850405

9

Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.

Bustad A, Terziivanov D, Leary R, Port R, Schumitzky A, Jelliffe R. Bustad A, et al. Among authors: schumitzky a. Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003. Clin Pharmacokinet. 2006. PMID: 16584284

10

Nonparametric population modeling and Bayesian analysis.

Jelliffe R, Neely M, Schumitzky A, Bayard D, Van Guilder M, Botnen A, Bustad A, Laing D, Yamada W, Bartroff J, Tatarinova T. Jelliffe R, et al. Among authors: schumitzky a. Pharmacol Res. 2011 Oct;64(4):426. doi: 10.1016/j.phrs.2011.04.008. Epub 2011 Apr 23. Pharmacol Res. 2011. PMID: 21699981 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters